blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2178900

EP2178900 - PURIFICATION OF PEGYLATED POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.03.2013
Database last updated on 12.06.2024
Most recent event   Tooltip14.06.2019Change - lapse in a contracting state
State(s) deleted from list of lapses: TR		published on 17.07.2019  [2019/29]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstraße 124
4070 Basel / CH
[N/P]
Former [2010/17]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / BURG, Josef
Merowingerstrasse 5
82362 Weilheim / DE
02 / REICHERT, Klaus
Bahnhofstrasse 12e
82386 Oberhausen / DE
03 / SCHROTH, Axel
Saliterstrasse 5
82404 Sindelsdorf / DE
04 / SCHURIG, Hartmut
Loerracher Strasse 36
79541 Loerrach / DE
05 / WESSNER, Axel
Poennenspercherstrasse 1
82377 Penzberg / DE
 [2010/17]
Representative(s)Burger, Alexander, et al
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[N/P]
Former [2010/17]Burger, Alexander, et al
Roche Diagnostics GmbH Patent Department (TR-E) Postfach 11 52
82372 Penzberg / DE
Application number, filing date08784775.215.07.2008
[2010/17]
WO2008EP05767
Priority number, dateEP2007001395917.07.2007         Original published format: EP 07013959
[2010/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009010270
Date:22.01.2009
Language:EN
[2009/04]
Type: A2 Application without search report 
No.:EP2178900
Date:28.04.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 22.01.2009 takes the place of the publication of the European patent application.
[2010/17]
Type: B1 Patent specification 
No.:EP2178900
Date:02.05.2012
Language:EN
[2012/18]
Search report(s)International search report - published on:EP30.04.2009
ClassificationIPC:C07K1/18, A61K38/18, A61K47/48
[2010/17]
CPC:
C07K1/18 (EP,KR,US); A61K38/18 (KR); A61K47/50 (KR);
A61K47/60 (EP,US); C07K14/505 (EP,US); C07K17/08 (KR)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/17]
TitleGerman:REINIGUNG PEGYLIERTER POLYPETIDE[2010/17]
English:PURIFICATION OF PEGYLATED POLYPEPTIDES[2010/17]
French:PURIFICATION DE POLYPEPTIDES PÉGYLÉES[2010/17]
Entry into regional phase17.02.2010National basic fee paid 
17.02.2010Designation fee(s) paid 
17.02.2010Examination fee paid 
Examination procedure15.05.2009Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.02.2010Examination requested  [2010/17]
02.08.2011Communication of intention to grant the patent
01.12.2011Fee for grant paid
01.12.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.08.2011
Opposition(s)05.02.2013No opposition filed within time limit [2013/15]
Fees paidRenewal fee
08.07.2010Renewal fee patent year 03
16.07.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
MT02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
LU15.07.2012
MC31.07.2012
BG02.08.2012
IS02.09.2012
[2019/29]
Former [2014/27]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
MT02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
LU15.07.2012
TR15.07.2012
MC31.07.2012
BG02.08.2012
IS02.09.2012
Former [2014/25]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
MT02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
TR15.07.2012
MC31.07.2012
BG02.08.2012
IS02.09.2012
Former [2013/34]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
MT02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
MC31.07.2012
BG02.08.2012
IS02.09.2012
Former [2013/11]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
MC31.07.2012
IS02.09.2012
Former [2013/10]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
RO02.05.2012
SI02.05.2012
SK02.05.2012
IS02.09.2012
Former [2013/09]CY02.05.2012
EE02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
SI02.05.2012
IS02.09.2012
Former [2012/51]CY02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
SI02.05.2012
IS02.09.2012
Former [2012/50]CY02.05.2012
HR02.05.2012
LT02.05.2012
LV02.05.2012
IS02.09.2012
Former [2012/49]CY02.05.2012
LT02.05.2012
IS02.09.2012
Former [2012/47]LT02.05.2012
Cited inInternational search[DY]EP1064951  (HOFFMANN LA ROCHE [CH]) [DY] 1-20 * example 5 *;
 [DX]WO0187329  (HOFFMANN LA ROCHE [CH]) [DX] 1-20 * example 2 *;
 [Y]WO2004009627  (CANGENE CORP [CA], et al) [Y] 1-20 * page 30, line 3 - line 6 *;
 [Y]WO2004012773  (HOFFMANN LA ROCHE [CH]) [Y] 1-20 * page 42, line 4 - page 43, line 2 *;
 [DX]WO2007039436  (HOFFMANN LA ROCHE [CH], et al) [DX] 1-20 * page 17, line 12 - column 2, line 22; example 1 *;
 [E]WO2009010271  (HOFFMANN LA ROCHE [CH], et al) [E] 1-20* the whole document *;
 [A]  - LONG ET AL, "Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, (200606), vol. 34, no. 6, ISSN 0301-472X, pages 697 - 704, XP005504760

DOI:   http://dx.doi.org/10.1016/j.exphem.2006.02.011
by applicantEP0530447
 WO0187329
 WO2004024866
 WO2007039436
    - DANIELSSON, A. ET AL., J. IMMUN. METH., (1988), vol. 115, pages 79 - 88
    - YU, G. ET AL., PROCESS BIOTECHNOL., (2007), vol. 42, pages 971 - 977
    - WANG, H. ET AL., PEPTIDES, (2005), vol. 26, pages 1213 - 1218
    - YUN, Q. ET AL., J. BIOTECHNOL., (2005), vol. 118, pages 67 - 74
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.